Reports on the launch of a gene therapy for Parkinson's disease by researchers at Weill Cornell Medical Center in New York. Aim of the gene therapy to increase the production of gamma-aminobutyric acid, a molecule that inhibits nerve activity; Concern over the safety of the gene transfer; List of biotechnology companies conducting research in gene therapy involving the brain.